George Hill
Stock Analyst at Deutsche Bank
(2.81)
# 1,322
Out of 5,182 analysts
194
Total ratings
51.24%
Success rate
4.29%
Average return
Main Sectors:
Stocks Rated by George Hill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Buy | $120 → $128 | $81.58 | +56.90% | 19 | Mar 19, 2026 | |
| WAY Waystar Holding | Maintains: Buy | $42 → $37 | $25.27 | +46.42% | 3 | Mar 12, 2026 | |
| TDOC Teladoc Health | Upgrades: Buy | $11 | $5.95 | +84.87% | 19 | Mar 10, 2026 | |
| HIMS Hims & Hers Health | Maintains: Hold | $25 → $28 | $26.33 | +6.34% | 5 | Mar 10, 2026 | |
| ELV Elevance Health | Downgrades: Hold | $332 → $320 | $376.63 | -15.04% | 3 | Dec 19, 2025 | |
| HUM Humana | Maintains: Hold | $250 → $231 | $243.12 | -4.99% | 12 | Nov 7, 2025 | |
| MCK McKesson | Maintains: Buy | $775 → $856 | $822.63 | +4.06% | 8 | Sep 24, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $521 → $362 | $370.74 | -2.36% | 22 | May 14, 2025 | |
| CVS CVS Health | Maintains: Buy | $66 → $70 | $83.90 | -16.57% | 7 | Feb 14, 2025 | |
| AGL agilon health | Maintains: Hold | $100 → $50 | $27.89 | +79.28% | 16 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $398 → $394 | $292.32 | +34.78% | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $119 → $124 | $202.82 | -38.86% | 12 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $1.97 | +1.52% | 14 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $5 | $0.93 | +435.05% | 4 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $82 → $87 | $53.98 | +61.17% | 10 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $353 | $196.49 | +79.65% | 9 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $461 → $471 | $232.32 | +102.74% | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $8 | $2.29 | +249.34% | 5 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $255 → $250 | $156.66 | +59.58% | 4 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $287 → $235 | $116.17 | +102.29% | 5 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $334 | $163.84 | +103.86% | 5 | Feb 18, 2021 |
HealthEquity
Mar 19, 2026
Maintains: Buy
Price Target: $120 → $128
Current: $81.58
Upside: +56.90%
Waystar Holding
Mar 12, 2026
Maintains: Buy
Price Target: $42 → $37
Current: $25.27
Upside: +46.42%
Teladoc Health
Mar 10, 2026
Upgrades: Buy
Price Target: $11
Current: $5.95
Upside: +84.87%
Hims & Hers Health
Mar 10, 2026
Maintains: Hold
Price Target: $25 → $28
Current: $26.33
Upside: +6.34%
Elevance Health
Dec 19, 2025
Downgrades: Hold
Price Target: $332 → $320
Current: $376.63
Upside: -15.04%
Humana
Nov 7, 2025
Maintains: Hold
Price Target: $250 → $231
Current: $243.12
Upside: -4.99%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $775 → $856
Current: $822.63
Upside: +4.06%
UnitedHealth Group
May 14, 2025
Maintains: Buy
Price Target: $521 → $362
Current: $370.74
Upside: -2.36%
CVS Health
Feb 14, 2025
Maintains: Buy
Price Target: $66 → $70
Current: $83.90
Upside: -16.57%
agilon health
Nov 8, 2024
Maintains: Hold
Price Target: $100 → $50
Current: $27.89
Upside: +79.28%
Nov 4, 2024
Maintains: Buy
Price Target: $398 → $394
Current: $292.32
Upside: +34.78%
Nov 4, 2024
Maintains: Hold
Price Target: $119 → $124
Current: $202.82
Upside: -38.86%
Aug 14, 2024
Maintains: Hold
Price Target: $5 → $2
Current: $1.97
Upside: +1.52%
Aug 9, 2024
Maintains: Hold
Price Target: $7 → $5
Current: $0.93
Upside: +435.05%
Aug 2, 2024
Maintains: Hold
Price Target: $82 → $87
Current: $53.98
Upside: +61.17%
Jul 29, 2024
Maintains: Hold
Price Target: $354 → $353
Current: $196.49
Upside: +79.65%
Sep 5, 2023
Maintains: Buy
Price Target: $461 → $471
Current: $232.32
Upside: +102.74%
Aug 10, 2023
Maintains: Hold
Price Target: $6 → $8
Current: $2.29
Upside: +249.34%
Mar 23, 2022
Maintains: Buy
Price Target: $255 → $250
Current: $156.66
Upside: +59.58%
Feb 25, 2022
Maintains: Hold
Price Target: $287 → $235
Current: $116.17
Upside: +102.29%
Feb 18, 2021
Maintains: Buy
Price Target: $250 → $334
Current: $163.84
Upside: +103.86%